198992-49-3 Usage
Description
2-Piperazinecarboxylic acid, methylester, (S)-(9CI) is a chemical compound with the molecular formula C7H13N3O2. It is a methyl ester derivative of 2-piperazinecarboxylic acid and belongs to the S-enantiomer class. 2-Piperazinecarboxylicacid,methylester,(S)-(9CI) is known for its potential as a central nervous system (CNS) depressant and has been studied for its potential applications in the treatment of neurological disorders.
Uses
Used in Pharmaceutical Industry:
2-Piperazinecarboxylic acid, methylester, (S)-(9CI) is used as a precursor in the synthesis of various drug molecules and pharmacological research. Its versatile properties make it an important compound in the field of medicinal chemistry.
Used in Neurological Disorders Treatment:
2-Piperazinecarboxylic acid, methylester, (S)-(9CI) is used as a potential treatment for neurological disorders due to its CNS depressant properties.
Used in Anti-Inflammatory Applications:
2-Piperazinecarboxylic acid, methylester, (S)-(9CI) has been investigated for its role in anti-inflammatory activities, making it a potential candidate for the development of anti-inflammatory drugs.
Used in Anti-Cancer Applications:
2-Piperazinecarboxylic acid, methylester, (S)-(9CI) has been studied for its potential role in anti-cancer activities, indicating its potential use in the development of cancer treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 198992-49-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,8,9,9 and 2 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 198992-49:
(8*1)+(7*9)+(6*8)+(5*9)+(4*9)+(3*2)+(2*4)+(1*9)=223
223 % 10 = 3
So 198992-49-3 is a valid CAS Registry Number.
198992-49-3Relevant articles and documents
Process for the preparation of optically active piperazine-2-carboxylic acid derivatives
-
, (2008/06/13)
Optically active piperazine-2-carboxylic acid derivatives of the general formula: STR1 in which X is alkoxy or a (substituted) amino group, are prepared by asymmetric hydrogenation of the corresponding pyrazinecarboxylic acid derivatives, catalyzed by optically active rhodium complexes. The compounds of the formula I are intermediates for the preparation of pharmaceutical active substances, for example, HIV protease inhibitors.
